Abstract
Renal masses are now being detected and properly staged earlier because of advances in imaging. Surgery remains as the gold standard for treatment, with partial nephrectomy as the treatment of choice for small renal masses. A less invasive, nephron-sparing treatment alternative is ablation therapy, especially offered to patients with small renal masses (3 to 4 cm or less), elderly patients, patients with impaired renal function, or patients with co-morbidity, as it entails less anesthetic requirements, lower cost, shorter hospital stay, faster recovery, and reduced mortality and morbidity. Such ablative techniques include radiofrequency and microwave ablation that can be done through open surgery, laparoscopic surgery, or image-guided percutaneous techniques. Evaluation prior to thermal ablation should include contrast-enhanced CT scan. A biopsy is also done prior to tumor ablation to confirm the diagnosis. Major complications, such as hemorrhage, are infrequent. Patients are followed up regularly with imaging to determine treatment success.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andreano A, Brace CL. A comparison of direct heating during radiofrequency and microwave ablation in ex vivo liver. Cardiovasc Intervent Radiol. 2013;36(2):505–11.
Atwell TD, Carter RE, Schmit GD, et al. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol. 2012;23(1):48–54.
Atwell TD, Farrell MA, Leibovich BC, et al. Percutaneous renal cryoablation: experience treating 115 tumors. J Urol. 2008;179(6):2136–40. discussion 2140-1
Atwell TD, Schmit GD, Boorjian SA, Mandrekar J, Kurup AN, Weisbrod AJ, et al. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol. 2013;200(2):461–6.
Boss A, Clasen S, Kuczyk M, Anastasiadis A, Schmidt D, Graf H, et al. Magnetic resonance-guided percutaneous radiofrequency ablation of renal cell carcinomas: a pilot clinical study. Investig Radiol. 2005;40:583–90.
Brace CL. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Curr Probl Diagn Radiol. 2009;38(3):135–43.
Breen D, Bryant TJ, Abbas A, Shepherd B, McGill N, Anderson JA, et al. Percutaneous cryoablation of renal tumours: outcomes from 171 tumours in 147 patients. BJU Int. 2013;112(6):758–65.
Breen DJ, Railton NJ. Minimally invasive treatment of small renal tumors: trends in renal cancer diagnosis and management. Cardiovasc Interv Radiol. 2010;33(5):896–908.
Breen DJ, Rutherford EE, Stedman B, Roy-Choudhury SH, Cast JEI, Hayes MC, et al. Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. Cardiovasc Interv Radiol. 2007;30(5):936–42.
Campbell SC, Krishnamurthi V, Chow G, Hale J, Myles J, Novick AC. Renal cryosurgery: experimental evaluations of treatment parameters. Urology. 1998;52(1):29–34.
Chiou YY, Hwang JI, Chou YH, Wang JH, Chiang JH, Chang CY. Percutaneous radiofrequency ablation of renal cell carcinoma. J Chin Med Assoc. 2005;68(5):221–5.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.
Fotiadis NI, Sabharwal T, Morales JP, Hodgson DJ, O’Brien TS, Adam A. Combined percutaneous radiofrequency ablation and ethanol injection of renal tumours: midterm results. Eur Urol. 2007;52(3):777–84.
Georgiades C, Rodriguez R. Renal tumor ablation. Tech Vasc Interv Radiol. 2013;16(4):230–8.
Georgiades CS, Rodriguez R. Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study. Cardiovasc Interv Radiol. 2014;37(6):1494–9.
Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma. Part 1. Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol. 2005;185:64–71.
Goldberg SN, Gazelle GS. Radiofrequency tissue ablation: physical principles and techniques for increasing coagulation necrosis. Hepato-Gastroenterology. 2001;48:359–67.
Gupta A, Allaf ME, Kavoussi LR, Jarrett TW, Chan DY, Su LM, et al. Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation: initial clinical experience. J Urol. 2006;175:447–52.
Hegarty NJ, Gill IS, Desai MM, Remer EM, O’Malley CM, Kaouk JH. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation. Urology. 2006;68(1 Suppl):7–13.
Hindman N, Ngo L, Genega EM, Melamed J, Wei J, Braza JM, et al. Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology. 2012;265(2):468–77.
Hinshaw JL, Lubner MG, Ziemlewicz TJ, Fred T, Lee FT Jr, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation—what should you use and why? Radiographics. 2014a;35:1344–62.
Hinshaw JL, Lubner MG, Ziemlewicz TJ, Fred T, Lee FT Jr, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation—what should you use and why? Radiographics. 2014b;35:1344–62.
Hui GC, Tuncali K, Tatli S, Morrison PR, Silverman SG. Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates. J Vasc Interv Radiol. 2008;19(9):1311–20.
Johnson DB, Solomon SB, Su LM, et al. Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. J Urol. 2004;172(3):874–7.
Kachura J, Baldassarre F, Kielar A, Baerlocher M. A quality initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) focal ablation 3: focal tumour ablation for renal cell carcinoma. 2016.
Kam AW, Littrup PJ, Walther MM, Hvizda J, Wood BJ. Thermal protection during percutaneous thermal ablation of renal cell carcinoma. J Vasc Interv Radiol. 2004;15(7):753–8.
Kim SD, Yoon SG, Sung GT. Radiofrequency ablation of renal tumors: four-year follow-up results in 47 patients. Korean J Radiol. 2012;13(5):625–33.
Krokidis M, Spiliopoulos S, Jarzabek M, Fotiadis N, Sabharwal T, O’Brien T, et al. Percutaneous radiofrequency ablation of small renal tumours in patients with a single functioning kidney: long-term results. Eur Radiol. 2013;23(7):1933–9.
Krokidis ME, et al. CIRSE guidelines on percutaneous ablation of small renal cell carcinoma. Cardiovasc Intervent Radiol. 2017;40(2):177–91.
Liang P, Wang Y. Microwave ablation of hepatocellular carcinoma. Oncology. 2007;72(Suppl 1):124–31.
McGovern FJ, Wood BJ, Goldberg SN, Mueller PR. Radiofrequency ablation of renal cell carcinoma via image guided needle electrodes. J Urol. 1999a;161(2):599–600.
Park BK, Kim CK. Complications of image-guided radiofrequency ablation of renal cell carcinoma: causes, imaging features and prevention methods. Eur Radiol. 2009;19(9):2180–90.
Park BK, Kim SH, Byun JY, Kim YS, Kwon GY, Jang IS. CT-guided instillation of 5% dextrose in water into the anterior pararenal space before renal radiofrequency ablation in a porcine model: positive and negative effects. J Vasc Interv Radiol. 2007;18:1561–9.
Paudice N, Zanazzi M, Agostini S, Bertelli E, Caroti L, Carta P, et al. Contrast-enhanced ultrasound assessment of complex cystic lesions in renal transplant recipients with acquired cystic kidney disease: preliminary experience. Transplant Proc. 2012;44(7):1928–9.
Pedrosa I, Sun MR, Spencer M, Genega EM, Olumi AF, Dewolf WC, et al. MR imaging of renal masses: correlation with findings at surgery. Radiographics. 2008;28(4):985–1003.
Ramanathan R, Leveillee RJ. Ablative therapies for renal tumors. Ther Adv Urol. 2010;2(2):51–68. https://doi.org/10.1177/1756287210366708.
Rosenkrantz AB, Hindman N, Fitzgerald EF, Niver BE, Melamed J, Babb JS. MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR Am J Roentgenol. 2010;195(6):W421–7.
Schmit GD, Kurup AN, Weisbrod AJ, Thompson RH, Boorjian SA, Wass CT, et al. ABLATE: a renal ablation planning algorithm. AJR Am J Roentgenol. 2014a;202(4):894–903.
Schmit GD, Schenck LA, Thompson RH, Boorjian SA, Kurup AN, Weisbrod AJ, et al. Predicting renal cryoablation complications: new risk score based on tumor size and location and patient history. Radiology. 2014b;272(3):903–10.
Silverman SG, Tuncali K, van Sonnenberg E, et al. Renal tumors: MR imaging-guided percutaneous cryotherapy—initial experience in 23 patients. Radiology. 2005;236(2):716–24.
Smith S, Gillams A. Imaging appearances following thermal ablation. Clin Radiol. 2008;63:1–11.
Tacke J, Mahnken A, Bucker A, Rohde D, Gunther RW. Nephron-sparing percutaneous ablation of a 5 cm renal cell carcinoma by superselective embolization and percutaneous RF ablation. Rofo. 2001;173:980–3.
Tacke J, Mahnken AH, Gunther RW. Percutaneous thermal ablation of renal neoplasms. Rofo. 2005;177:1631–40.
Takaki H, Yamakado K, Soga N, Arima K, Nakatsuka A, Kashima M, et al. Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma. Jpn J Radiol. 2010;28(6):460–8.
Uppot RN, Silverman SG, Zagoria RJ, Tuncali K, Childs DD, Gervais DA. Imaging-guided percutaneous ablation of renal cell carcinoma: a primer of how we do it. AJR Am J Roentgenol. 2009;192(6):1558–70.
Veltri A, De Fazio G, Malfitana V, Isolato G, Fontana D, Tizzani A, et al. Percutaneous US-guided RF thermal ablation for malignant renal tumors: preliminary results in 13 patients. Eur Radiol. 2004;14:2303–10.
Veltri A, Gazzera C, Busso M, Solitro F, Piccoli GB, Andreetto B, et al. T1a as the sole selection criterion for RFA of renal masses: randomized controlled trials versus surgery should not be postponed. Cardiovasc Interv Radiol. 2014;37(5):1292–8.
Wah TM, Koenig P, Irving HC, Gervais DA, Mueller PR. Radiofrequency ablation of a central renal tumour: protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique. J Vasc Interv Radiol. 2005;16(11):1551–5.
Warshauer DM, McCarthy SM, Street L, Bookbinder MJ, Glickman MG, Richter J, et al. Detection of renal masses: sensitivities and specificities of excretory urography/linear tomography, US, and CT. Radiology. 1988;169(2):363–5.
Weld KJ, Hruby G, Humphrey PA, Ames CD, Landman J. Precise characterization of renal parenchymal response to single and multiple cryoablation probes. J Urol. 2006;176(2):784–6.
Williams SK, de la Rosette J, Landman J, Keely F. Cryoablation of small renal tumors. EAU-EBU Update Series. 2007;5:206–2018.
Zagoria RJ, Hawkins AD, Clark PE, Hall MC, Matlaga BR, Dyer RB, et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR. 2004a;183:201–7.
Zagoria RJ, Hawkins AD, Clark PE, Hall MC, Matlaga BR, Dyer RB, et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR. 2004b;183:201–7.
Zagoria RJ, Pettus JA, Rogers M, Werle DM, Childs D, Leyendecker JR. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology. 2011;77(6):1393–7.
Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol. 2007;189(2):429–36.
Zargar H, Atwell TD, Cadeddu JA, de la Rosette JJ, Janetschek G, Kaouk JH, et al. Cryoablation for small renal masses:selection criteria, complications, and functional and oncologic results. Eur Urol. 2016;69(1):116–28.
Zorn KC, Orvieto MA, Mikhail AA, Lyon MB, Gerber GS, Steinberg GD, et al. Case report: radiofrequency ablation-induced renal-pelvic obstruction resulting in nephrectomy. J Endourol. 2007;21(9):1059–63.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Aldana, J.P.A., Catibog, J.J.S., Sotalbo, C.P.J., Yabut, J.A.O. (2019). Thermal Ablation for Small Renal Masses. In: Chan, Ey., Matsuda, T. (eds) Endourology Progress. Springer, Singapore. https://doi.org/10.1007/978-981-13-3465-8_32
Download citation
DOI: https://doi.org/10.1007/978-981-13-3465-8_32
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-3464-1
Online ISBN: 978-981-13-3465-8
eBook Packages: MedicineMedicine (R0)